Biosistemak, part of EuCanScreen for cancer detection

Basque innovation in the fight against cancer

Biosistemak

Innovation from the Basque Country

Biosistemak is one of the Basque health research Institutes specialising in the evaluation of health technologies and services and the improvement of health systems. As a leader in implementing innovative solutions, Biosistemak addresses key challenges of the health and care sector, keeping people at the centre of the system. The institute carries out applied and translational research in the management and organisation of health and social healthcare systems, in line with the policies of the Department of Health of the Basque Government. Its activities include the evaluation of policies and services, the development of intervention models, the analysis of health services change and their implementation and the training of research professionals in health services.

 

Furthermore, Biosistemak aims to and transfer the applied research to clinical practice and health management, and where appropriate, to public health programmes and social innovation. This work aims to improve the efficiency, equity and safety of the healthcare system. Additionally, the Institute also collaborates with other agents to generate social and economic value, positioning the Basque Country as an international reference in healthcare innovation.

 

Role of Biosistemak in EuCanScreen

The Biosistemak institute plays a key role as the representative of the Basque Country within the framework of EuCanScreen. Together with Osakidetza Basque Health Service and the Department of Health of the Basque Government, the institute actively contributes to the implementation of this ambitious European project. Its participation is focused on several transversal work packages that provide methodology and guidelines for the execution of pilot projects, highlighting:

 

  • – Developing new screening tests (prostate cancer)
  • – Risk-based screening tests (colorectal, breast and cervical cancer)
  • – Modelling and evaluating health technologies to optimise screening programmes.

 

It is also participating in a pilot project to implement a screening programme in Basque Country for the early detection of prostate cancer.

 

In this sense, EUCanScreen is aligned with the strategic objectives of the Basque Government Health Plan 2030, which seeks to lead a healthier Basque Country, reduce health inequalities and promote innovation to improve health outcomes.

Subscribe to our newsletter to get news and updates.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen Vertical

 

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

tiktok

FaceBook

X

Instagram

YouTube

LinkedIn

email

EUCanScreenLogo t

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

FaceBook

Twitter

Instagram

YouTube

LinkedIn

Logo EU

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959

Print Friendly, PDF & Email
Μετάβαση στο περιεχόμενο